Globus Medical Cash Flow Statement
GMED / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Globus Medical generated $753M in operating cash flow and $589M in free cash flow in FY2025. Free cash flow margin was 20.0% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $537.9M | $103.0M | $122.9M | $190.2M | $155.2M | $156.5M | $155.2M | $156.5M | $107.3M | $104.3M | $112.8M | $92.5M | $68.6M | $73.8M | $60.8M |
| Depreciation & Amortization | $276.8M | $253.4M | $145.5M | $68.3M | $52.7M | $41.6M | $52.7M | $41.6M | $42.1M | $38.8M | $24.1M | $21.8M | $19.4M | $18.1M | $16.9M |
| Operating Cash Flow | $753.4M | $520.6M | $243.5M | $178.5M | $172.0M | $181.6M | $172.0M | $181.6M | $159.1M | $147.8M | $124.0M | $79.2M | $93.5M | $76.5M | $76.4M |
| Capital Expenditures | $164.7M | $115.4M | $78.3M | $74.0M | $70.8M | $59.7M | $70.8M | $59.7M | $51.3M | $40.9M | $50.8M | $24.8M | $23.7M | $24.7M | $22.5M |
| Free Cash Flow | $588.8M | $405.2M | $165.2M | $104.4M | $101.2M | $121.9M | $101.2M | $121.9M | $107.8M | $106.9M | $73.2M | $54.4M | $69.8M | $51.8M | $53.9M |
| Share Buybacks | $300.5M | $85.8M | $225.6M | $144.5M | $104.7M | $104.7M | - | - | - | - | - | - | $0 | $0 | $10.0M |
| FCF Margin | 20.0% | 16.1% | 10.5% | 10.2% | 12.9% | 17.1% | 12.9% | 17.1% | 16.9% | 19.0% | 13.5% | 11.5% | 16.1% | 13.4% | 16.3% |